BeOne Medicines (ONC) Revenue Growth (1y) (2016 - 2026)
BeOne Medicines (ONC) Revenue Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 96.43% |
| 10 | Revolution Medicines | 37.26 Bn | 37.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.46% |
| Dec 31, 2025 | 32.84% |
| Sep 30, 2025 | 41.00% |
| Jun 30, 2025 | 41.56% |
| Mar 31, 2025 | 48.64% |
| Dec 31, 2024 | 77.78% |
| Sep 30, 2024 | 28.20% |
| Jun 30, 2024 | 56.09% |
| Mar 31, 2024 | 67.85% |
| Dec 31, 2023 | 66.91% |
| Sep 30, 2023 | 101.56% |
| Jun 30, 2023 | 74.27% |
| Mar 31, 2023 | 46.04% |
| Dec 31, 2022 | 77.63% |
| Sep 30, 2022 | 87.77% |
| Jun 30, 2022 | 127.73% |
| Mar 31, 2022 | -49.39% |
| Dec 31, 2021 | 113.77% |
| Sep 30, 2021 | 126.66% |
| Jun 30, 2021 | 128.52% |